bruceine d has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, J; Ma, Z; Nie, Y; Yang, B; Zhang, L | 1 |
| Baek, J; Cho, S; Choi, M; Choi, S; Ham, Y; Han, SB; Jeong, H; Jo, YH; Kang, M; Kim, J; Kim, SY; Lee, SW; Oh, SR; Ryu, HW; Shen, H; Son, B; Sydara, K | 1 |
| Cai, Y; Ding, Q; Hao, Y; Kong, F; Tang, B; Yang, Y | 1 |
3 other study(ies) available for bruceine d and Disease Models, Animal
| Article | Year |
|---|---|
Bruceine D ameliorates the balance of Th1/Th2 in a mouse model of ovalbumin-induced allergic asthma via inhibiting the NOTCH pathway.
Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Brucea javanica; Cytokines; Disease Models, Animal; Inflammation; Lung; Mice; Mice, Inbred BALB C; Ovalbumin; Quassins; Receptors, Notch; Th1-Th2 Balance | 2021 |
Improvement of spinal muscular atrophy via correction of the SMN2 splicing defect by Brucea javanica (L.) Merr. extract and Bruceine D.
Topics: Alternative Splicing; Animals; Brucea; Cell Line; Disease Models, Animal; Drug Evaluation, Preclinical; Exons; Humans; Mice, Transgenic; Muscular Atrophy, Spinal; Plant Extracts; Quassins; RNA, Messenger; Survival of Motor Neuron 2 Protein | 2019 |
Bruceine D elevates Nrf2 activation to restrain Parkinson's disease in mice through suppressing oxidative stress and inflammatory response.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Dopaminergic Neurons; Inflammation; Male; Mice, Inbred C57BL; Nerve Degeneration; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Parkinson Disease; Quassins; Signal Transduction | 2020 |